Nektar Therapeutics
NKTR
#4786
Rank
A$3.11 B
Marketcap
A$92.24
Share price
2.61%
Change (1 day)
107.35%
Change (1 year)

Nektar Therapeutics (NKTR) - Total debt

Total debt on the balance sheet as of March 2026 : A$0.12 Billion

According to Nektar Therapeutics 's latest financial reports the company's total debt is A$0.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Nektar Therapeutics - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.12 B-22.36%
2024-12-31A$0.16 B-4.61%
2023-12-31A$0.17 B-10.54%
2022-12-31A$0.19 B-2.16%
2021-12-31A$0.19 B1.04%
2020-12-31A$0.19 B-66.47%
2019-12-31A$0.58 B66.29%
2018-12-31A$0.35 B11.61%
2017-12-31A$0.31 B-7.01%
2016-12-31A$0.33 B-0.6%
2015-12-31A$0.33 B108.06%
2014-12-31A$0.16 B6.65%
2013-12-31A$0.15 B16.49%
2012-12-31A$0.13 B-41.28%
2011-12-31A$0.22 B-1.97%
2010-12-31A$0.22 B-12.24%
2009-12-31A$0.26 B-21.98%
2008-12-31A$0.33 B-13.38%
2007-12-31A$0.38 B-30.72%
2006-12-31A$0.55 B-7.24%
2005-12-31A$0.59 B132.92%
2004-12-31A$0.25 B-51.38%
2003-12-31A$0.52 B-10.21%
2002-12-31A$0.58 B-9.37%
2001-12-31A$0.65 B13.52%
2000-12-31A$0.57 B231.98%
1999-12-31A$0.17 B2011.44%
1998-12-31A$8.17 M2.69%
1997-12-31A$7.95 M1480.57%
1996-12-31A$0.5 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$79.68 B 66,020.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$92.35 B 76,533.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$83.06 B 68,829.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$14.03 B 11,548.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$71.17 B 58,961.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$49.15 B 40,685.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$2.52 M-97.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$2.29 B 1,801.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland